Craneware Share Discussion Threads

[lomax99] 25/1/2023 11:45

Small top-up for me.

[richtea2517] 23/1/2023 13:08

Is this oversold now ?

[peddlers] 03/1/2023 16:26

Bought some Craneware.
Fundamentals and the chart looking good.
Short term target 3000.
Good luck.

Ped

[johnrxx99] 16/11/2022 08:11

The NT is in. Any comments?

[kemche] 23/6/2022 15:14

Next one to be taken out?

[chasbas] 13/5/2022 15:36

RSI=20 meaning oversold at 1430p. Does anybody know of any reason why other than general crash in US technology stocks? Current PER is 20 for year to June with following year 18. Not cheap but not expensive IMO for a technology growth stock

[km18] 15/2/2022 18:10

...from last year....

Company overview:
Today’s company provides healthcare institutions with something crucial for the long-term prosperity of such entities – optimization of financial and operational performance. The firm argues that roughly $22 million in revenue are not captured from the average 350-bed hospital, and that is a lot even in the world of hyper expensive testing and analysis robots a modern hospital has. Craneware’s ambition is to reduce the foregone profits through its cycle experts and innovative technology which ensure transparency. They have 11  key products in their portfolio, which tackle different parts of the revenue generation cycle of each hospital. The company was founded in 1999 and currently has offices in UK and USA ad serves more than 1/3rd of the registered hospitals on US soil.
The company is growing organically, without any big acquisitions during the past 10 years. Goodwill for the period ending June 2021 was at $11.1m, or 3% which is negligible. Growth in the fundamentals is strong, with revenue CAGR of 8.68% and EPS at 4.06%. Return on capital employed is growing at 25.5% on compound basis and net gearing is negative. Return on equity is in the top quartile of the industry at 7.9% and dividends are growing at 11.6% CAGR.
Today they have released their final results for the FY 2021 (ending in June). Revenue swelled by 6% reaching $75.6m. PBT is below last year’s figures at $13.2m due to exceptional costs from the acquisition they did. As a result, EPS is down on 2020 figures to 48.1 cents. They have increased their expenditures on R&D and proposed an increase in dividends from 18.45 cents to 21.47 cents. Outlook is positive and momentum in sales is sustained in the new financial period. Management is “ confident in return to double digit organic growth”....from WealthOracleAM

[bagpuss67] 09/2/2022 11:30

Still going down any thoughts anyone?

[bagpuss67] 31/1/2022 15:08

What's happening here.. The trading statement looked OK?

[jombaston] 10/6/2021 16:42

I agree rimau, the chances are that this is a good entry point. However, quantifying the company's prospects is very difficult. I don't know if any of the three brokers have put out any research or what their guesses are for the future.

The company state the the acquisition will be at least double-digit accretive to June 2022 eps(before synergies). You'd certainly hope so given that they are buying a company with higher revenues than themselves and only funding half of it with equity! So this doesn't tell us much at all...did they really raise £140m without communicating a bit more than this to investors?

Again, I don't disagree with any of the positive points made but I do believe that it is not just the placing that private investors are being shut out of.

[rimau1] 09/6/2021 08:07

The good news for private investors is that you can now buy below the placing price. High quality company and i am happy to buy back having exited last year. £21.50 and i will add more if it falls further, acquisition looks compelling given that only 33% of Sentry customers are existing CRW clients. Given high barriers to entry this is a huge cross selling opportunity.

[zipstuck] 08/6/2021 15:28

Seems though the main part of the purchase covers the debt in Sentry so the EBITDA looks ok without it.

The tax losses will help as well

[jombaston] 08/6/2021 12:10

They have shown scant regard for the principles of pre-emption and yet they have the nerve to put out this statement:

"Craneware consulted with a number of its major shareholders prior to the Placing and has respected the principles of pre-emption through the allocation process. The Company is pleased by the support it has received from both existing and new shareholders."

Of course, all the major shareholders knew this was coming hence the drift down in the share price. But not to save even a small amount for private investors is very disappointing especially for a 23% dilution.

I might buy some more except I haven't seen or heard the presentation that the institutions have.

Last year Diploma, a FTSE 250 member and much bigger company than CRW, made a 10% equity raise for an acquisition and gave shareholders a chance to buy through PrimaryBid. Why can't these guys do this?

I agree it would be nice for all shareholders to be treated equally but shouldn't it be mandatory?

[undervaluedassets] 08/6/2021 09:27

right so we just have to take this dilution on the chin

I hope the acquisition is worth it.

Short term downward pressure on the shares looks inevitable.

Would have been nice for the ordinary shareholder to have had the opportunity to participate.

[jonut] 20/4/2021 21:28

Rush of blood to bonce yesterday when CRW broke through my upper trend line at £25.50.Broker wouldn't give an online quote so settled on a limit at 25.50. Ask was at 26 within 10 minutes. Disinclined to increase, I left it expecting CRW to carry on up.
Close of business showed my limit accepted!

Today the ask remained at £26 but the bid dropped to 24.50. Chanced a quote, to be bid 25.60 and took it.

I should, of course be buying when the price falls through the bottom trend line but it does make you wonder what the MM's are playing at. Looking at the trades today, there are lots ~25.50 marked as buys.

Nearly made a quid anyway.

[thetwentiestrader] 04/3/2021 17:53

Hi all, a new article on Craneware has been posted to my website, looking at the recent update and analysis of the financials. Available here: hxxps://www.thetwentiestrader.com/post/will-cranewares-migration-to-cloud-based-software-be-positive-for-its-shares

[energeticbacker] 01/3/2021 15:45

Investor's Champion comments:

Trading at 44x forecast earnings for the current financial year ending, the rating looks full on this simple measure, but Craneware has the attraction of plenty of visibility and growth potential in a highly supportive market going through significant change.

[masurenguy] 31/1/2021 14:04

Good recent H1 update !

"The Group has delivered a strong performance in the first half of the year against the ongoing backdrop of the pandemic and a volatile dollar exchange rate. The increased sales momentum has resulted in growth at both the revenue and adjusted EBITDA levels of greater than 5% compared to the first half of the prior year (HY20 Revenue: $35.9m, adjusted EBITDA $12.7m). The Group secured new sales at a significantly higher level than in the first half of the prior year; the Group’s customer retention rate has remained above 90% and the dollar renewal rate of customers at the end of their multi-year contracts has returned to approximately 100%; all building the foundation for a return to double-digit growth in the future. The Group’s cash reserves remain healthy, delivering ongoing cash conversion rate in excess of 100%.

The Group continues to see significant new opportunities entering the sales pipeline and the Board is confident in the continued positive performance of the business and its ability to meet current market expectations1 for the full year ending 30 June 2021 while being cognisant of the macro environment."

[bunz3] 21/1/2021 14:49

that video now on ggp share board , a good example for other shares

[rimau1] 20/1/2021 08:58

Good solid update. I have sold out this morning mainly because of US dollar earnings exposure and the share price has rerated over the past 6 months, high quality company and i will reinvest if it falls back during the year.

[rimau1] 14/1/2021 11:35

I’ve been topping up recently, clearly the market expects a positive TU this month. Given the democrats control the senate the outlook should be bullish IMO. Strong buy at these levels and expect to hit all time highs in Q1

[rimau1] 17/11/2020 10:23

That was an excellent update, basically growth has returned to normalised levels so this should return to previous highs, my target price is £2900. I couldn’t resist a small top up this morning when stock was available at £1980. Quality company with an excellent outlook deserving of a premium rating

[jonut] 16/11/2020 10:36

AGM tomorrow. share price up about 25% over the last month on thinnish volumes. On dummy trades, bid is usually at the mid price.

[jw330] 07/11/2020 09:13

the major concern here for me is the dollar exchange rate. The pound has fallen off so far due to Brexit and COVID that if it strengthens it could be detrimental to returns?